About
Geninus develops a proprietary multimodal spatial genomics platform, IntelliMed™, which integrates diverse patient tissue data to discover and prioritize novel therapeutic targets and target pairs for cancer treatment.
Explore Geninus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.